Phytochemical Profiling and Bioactive Potential of Rhizoclonium hookeri , Antioxidant, Antidiabetic, and Neuroprotective Effects
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Luqman Shah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany, Islamia College Peshawar, Peshawar, Pakistan. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Antioxidants, Diabetes Mellitus, Experimental, Neuroprotective Agents. Die Arbeit nennt 118 Literaturangaben.
Abstract (Originalsprache)
During the past two decades, algal‐derived chemical constituents have garnered considerable attention, particularly for their pharmaceutical and nutraceutical applications. In this study, the phytochemical composition of the freshwater alga Rhizoclonium hookeri was investigated, alongside an evaluation of its pharmacological potential. Results of the study revealed that the total phenolic content (TPC) and total flavonoid content (TFC) were found to be higher in n ‐butanol compared to DCM extract. Antioxidant activity evaluated by ABTS, DPPH, and H 2 O 2 assays demonstrated higher antioxidant potential by DCM extract, exhibiting distinct IC 50 values for each assay. In vivo antidiabetic assays revealed that the DCM extract significantly reduced blood glucose levels in alloxan‐induced diabetic rats, with marked reductions observed from the first day of treatment (85.33 ± 4.13 mg/dL). Furthermore, the DCM extract exhibited stronger α‐amylase inhibitory activity than the n ‐butanol extract, with IC 50 values of 48.18 and 404.06 µg/mL, respectively. Neurobehavioral assessments indicated that both extracts enhanced locomotor activity in the open‐field test, with the n ‐butanol extract demonstrating a slightly higher anti‐anxiolytic effect. In addition, acetylcholinesterase inhibition assays showed that the DCM extract possessed a more potent inhibitory effect (IC 50 = 15.71 µg/mL) compared to the n ‐butanol extract (IC 50 = 63.25 µg/mL). Collectively, these results demonstrate that R. hookeri extracts possess significant bioactive constituents and exhibit potent pharmacological activities, with the DCM extract showing enhanced antioxidant, antidiabetic, neurobehavioral, and enzyme inhibitory effects. These findings highlight the potential of R. hookeri as a promising source for the development of novel therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Botany, Islamia College Peshawar, Peshawar, Pakistan.
- Department of Pharmacy, Bacha Khan University, Charsadda, Pakistan.
- Center For Health Research, Northern Border University, Arar, Saudi Arabia.
- Department of Biotechnology, Abdul Wali Khan University, Mardan, Pakistan.
ORCID-Profile: Luqman Shah, Eman Ramadan Elsharkawy
Zitieren
APA
Shah, L., Iqbal, A., Imran, M., Jan, M. S., Elsharkawy, E. R., & Shah, Z. (2025). Phytochemical Profiling and Bioactive Potential of Rhizoclonium hookeri , Antioxidant, Antidiabetic, and Neuroprotective Effects. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500947
Vancouver
Shah L, Iqbal A, Imran M, Jan MS, Elsharkawy ER, Shah Z. Phytochemical Profiling and Bioactive Potential of Rhizoclonium hookeri , Antioxidant, Antidiabetic, and Neuroprotective Effects. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500947
BibTeX
@article{Shah2025,
author = {Shah, Luqman and Iqbal, Arshad and Imran, Muhammad and Jan, Muhammad Saeed and Elsharkawy, Eman Ramadan and Shah, Zamarud},
title = {Phytochemical Profiling and Bioactive Potential of Rhizoclonium hookeri , Antioxidant, Antidiabetic, and Neuroprotective Effects},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500947}
}
EUVIMED